Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-020843
Filing Date
2023-03-23
Accepted
2023-03-23 19:32:31
Documents
2
Period of Report
2023-03-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1595
2 POA DOCUMENT poa.txt EX-24 3608
  Complete submission text file 0001209191-23-020843.txt   6709
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Issuer) CIK: 0001408443 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TRIUS THERAPEUTICS, INC. 6310 NANCY RIDGE DRIVE, SUITE 101 SAN DIEGO CA 92121
Business Address
Fischer Seth H. Z. (Reporting) CIK: 0001573553 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38899 | Film No.: 23757445